Developer docs
API playgroundTry for free, no card

Search company profiles

Basavatarakam Indo American Cancer Hospital & Research Institute

Full company profile

uuid003ipwz

Namestring
Basavatarakam Indo American Cancer Hospital & Research Institute
Legal namestring
Basavatarakam Indo American Cancer Hospital & Research Institute
Websiteurl
induscancer.com
Company typeenum
Private
Founded yearint
2000
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, radiation oncology, surgical oncology, medical oncology, bone marrow transplant
Industry3 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
3Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
CodeHLAFAKABPrimaryNo
NAICS code1 code
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code2 codes
  • Services-Hospitals8060
  • Services-Health Services8000
Product category
Oncology Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Treatment Services
TypeSubscription Recurring
Description

Healthcare services provided to patients including surgical, medical, and radiation oncology treatments. The hospital is a non-profit trust providing world-class cancer treatment at affordable prices, with significant funds allocated annually for underprivileged patients.

basavatarakam.org
2Government Healthcare Schemes
TypeTransaction Fee
Description

Reimbursements from government schemes such as Aarogyasri and Employee Health Scheme for eligible patients.

basavatarakam.org
3Donations and Charitable Contributions
TypeAffiliate Referral
Description

Donations from individuals, trusts, foundations, and organizations supporting the hospital's mission of affordable cancer care.

basavatarakam.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1General Patient Services
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based / Not publicly disclosed. Payment made at time of visit to hospital.

basavatarakam.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital providing comprehensive cancer diagnosis, treatment, and research services including surgical oncology, medical oncology, and radiation oncology. The hospital operates advanced medical technology including PET CT with Cyclotron, Tomotherapy, robotic surgery systems, and six linear accelerators. It also runs a Bone Marrow Transplant unit, dedicated international patient coordination, DNB/PG medical training programs, and nursing and paramedical education, supported by scientific collaboration with Weill Cornell and Presbyterian Hospital, New York.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 250,925+ individuals screened through 1,339 screening camps
+2 more records
Product overview1 text field

Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital offering comprehensive cancer care through an integrated multi-disciplinary approach. The hospital provides a unified suite of oncology services organized into three core treatment streams: Surgical Oncology, Medical Oncology, and Radiation Oncology (with scientific support from Weill Cornell and Presbyterian Hospital, New York). These core services are supported by advanced diagnostic imaging technologies (PET CT with Cyclotron, SPECT, 3D Digital Mammography/Tomosynthesis, Gamma Camera Scan), cutting-edge treatment equipment (6 Linear Accelerators including Varian Novalis Tx with Rapid Arc/VMAT/Brain Lab, Tomotherapy, Robotic Surgery, Versa HD, Brachytherapy, IORT), and a state-of-the-art Bone Marrow Transplant unit. The hospital also offers digital patient services including online appointment booking across all departments and a Cancer Risk Assessment WebApp. Education and research divisions offer DNB/PG programs, nursing education (School and College of Nursing), and paramedical courses. International patient services with dedicated coordination are also available.

Product and service1 record
1Surgical Oncology
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or Integration
Description

Scientific support provided to the Radiation Oncology department since its inception in 2000, enhancing treatment protocols and expertise.

Strategic tierCoreTypeTechnology or Integration
Description

Major donor providing advanced radiation therapy equipment and technology support for the hospital's radiation oncology department.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding donor and strategic partner supporting the establishment and mission of the hospital as a joint Indo-American initiative.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International referral partner sending patients to the hospital for advanced cancer treatment.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International referral partner sending patients to the hospital for advanced cancer treatment.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International referral partner sending patients to the hospital for advanced cancer treatment.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International referral partner sending patients to the hospital for advanced cancer treatment.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International healthcare referral partner in the USA connecting patients with the hospital's services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Recognizes the hospital for conducting DNB/PG programmes for doctors in various oncology specializations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Multi-specialty hospital group with dedicated cancer programs across North India offering radiation oncology, BMT, and surgical oncology — comparable in technology and academic depth but as part of a listed for-profit chain.

TypeOthers
Description

Indian non-profit organizations focused on cancer awareness, screening camps, and patient support — adjacent peer reflecting the charitable cancer-care ecosystem that BIACH participates in for community outreach and underprivileged patient funding.

TypeBroad incumbent
Description

Large hospital chain with dedicated cancer centers across India including Hyderabad, offering surgical, medical, and radiation oncology with PET CT, LINACs, and BMT — comparable services but as part of a multi-specialty for-profit group with broader footprint.

TypeBroad incumbent
Description

US-based specialty oncology network (now part of City of Hope) offering integrated cancer care with strong translational research and academic programs — analogous in mission to integrate research, training, and multi-modality cancer treatment.

TypeDirect peer
Description

India's premier public specialty cancer hospital based in Mumbai, offering comprehensive surgical, medical, and radiation oncology with extensive research and DNB training programs — directly comparable in scope, mission, and academic depth to BIACH.

TypeDirect peer
Description

India's largest cancer hospital chain with multiple centers including Hyderabad, specializing in medical, surgical, and radiation oncology with advanced LINAC fleets and BMT — closest pure-play oncology network peer in scale and tech stack.

TypeBroad incumbent
Description

Multi-specialty tertiary hospital in Gurugram/Delhi NCR with dedicated cancer care division including radiation, medical, and surgical oncology — comparable in equipment breadth (LINACs, PET CT, robotic surgery) but with broader non-oncology portfolio.

TypeDirect peer
Description

Not-for-profit specialty cancer hospital in Delhi offering comprehensive oncology services, NABH accreditation, and academic programs — a close analogue in nonprofit trust structure and tertiary cancer care scope.

9Basel Cancer Institute (University Hospital Basel)
TypeRegional player
Description

European specialty cancer center combining clinical care, research, and teaching — a useful cross-regional benchmark for academic comprehensive cancer center operations though it serves a different geography.

TypeDirect peer
Description

Premier public academic medical institution with dedicated cancer treatment facilities (Dr. B.R.A. IRCH) in Delhi — comparable in academic mission, subsidized care, and tertiary oncology scope as a public-sector trust analogue.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Basavatarakam Indo American Cancer Hospital & Research Institute

Oncology Healthcare Servicesinduscancer.com

Basavatarakam Indo American Cancer Hospital & Research Institute firmographics

Firmographics
Name
Basavatarakam Indo American Cancer Hospital & Research Institute
Legal name
Basavatarakam Indo American Cancer Hospital & Research Institute
Website
https://induscancer.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
5,001–10,000 employees
Ownership category
akta.pro rank

Basavatarakam Indo American Cancer Hospital & Research Institute industry classification

Industry
Product category
Oncology Healthcare Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-Hospitals (8060), Services-Health Services (8000)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

  • Cancer treatment services
  • Radiation oncology
  • Surgical oncology
  • Medical oncology
  • Bone marrow transplant

Where Basavatarakam Indo American Cancer Hospital & Research Institute is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Basavatarakam Indo American Cancer Hospital & Research Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Patient Treatment Services: Healthcare services provided to patients including surgical, medical, and radiation oncology treatments. The hospital is a non-profit trust providing world-class cancer treatment at affordable prices, with significant funds allocated annually for underprivileged patients.
  2. Government Healthcare Schemes: Reimbursements from government schemes such as Aarogyasri and Employee Health Scheme for eligible patients.
  3. Donations and Charitable Contributions: Donations from individuals, trusts, foundations, and organizations supporting the hospital's mission of affordable cancer care.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goGeneral Patient Services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Basavatarakam Indo American Cancer Hospital & Research Institute product offering

Product offering

Core offering

Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital providing comprehensive cancer diagnosis, treatment, and research services including surgical oncology, medical oncology, and radiation oncology. The hospital operates advanced medical technology including PET CT with Cyclotron, Tomotherapy, robotic surgery systems, and six linear accelerators. It also runs a Bone Marrow Transplant unit, dedicated international patient coordination, DNB/PG medical training programs, and nursing and paramedical education, supported by scientific collaboration with Weill Cornell and Presbyterian Hospital, New York.

Product overview

Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital offering comprehensive cancer care through an integrated multi-disciplinary approach. The hospital provides a unified suite of oncology services organized into three core treatment streams: Surgical Oncology, Medical Oncology, and Radiation Oncology (with scientific support from Weill Cornell and Presbyterian Hospital, New York). These core services are supported by advanced diagnostic imaging technologies (PET CT with Cyclotron, SPECT, 3D Digital Mammography/Tomosynthesis, Gamma Camera Scan), cutting-edge treatment equipment (6 Linear Accelerators including Varian Novalis Tx with Rapid Arc/VMAT/Brain Lab, Tomotherapy, Robotic Surgery, Versa HD, Brachytherapy, IORT), and a state-of-the-art Bone Marrow Transplant unit. The hospital also offers digital patient services including online appointment booking across all departments and a Cancer Risk Assessment WebApp. Education and research divisions offer DNB/PG programs, nursing education (School and College of Nursing), and paramedical courses. International patient services with dedicated coordination are also available.

Differentiator

Problem solved

Functional benefit

Products and services

  • Surgical Oncology

Quantifiable outcome

  • 250,925+ individuals screened through 1,339 screening camps
  • +2 more outcomes

Companies that use Basavatarakam Indo American Cancer Hospital & Research Institute

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Basavatarakam Indo American Cancer Hospital & Research Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Basavatarakam Indo American Cancer Hospital & Research Institute partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Weill Cornell and Presbyterian Hospital, New YorkcoreTechnology or IntegrationScientific support provided to the Radiation Oncology department since its inception in 2000, enhancing treatment protocols and expertise.
  • Varian Medical SystemscoreTechnology or IntegrationMajor donor providing advanced radiation therapy equipment and technology support for the hospital's radiation oncology department.
  • Indo American Cancer Organisation (U.S.A.)coreStrategic or Co-development PartnerFounding donor and strategic partner supporting the establishment and mission of the hospital as a joint Indo-American initiative.
  • ADK Medical Centre, MaldivesminorChannel Partner/ Reseller/ DistributorInternational referral partner sending patients to the hospital for advanced cancer treatment.
  • Case Medical Centre, UgandaminorChannel Partner/ Reseller/ DistributorInternational referral partner sending patients to the hospital for advanced cancer treatment.
  • St. Catherine's Hospital, UgandaminorChannel Partner/ Reseller/ DistributorInternational referral partner sending patients to the hospital for advanced cancer treatment.
  • Grande Hospital, NepalminorChannel Partner/ Reseller/ DistributorInternational referral partner sending patients to the hospital for advanced cancer treatment.
  • AK Global Health, USAminorChannel Partner/ Reseller/ DistributorInternational healthcare referral partner in the USA connecting patients with the hospital's services.
  • National Board of Examination, New DelhicoreStrategic or Co-development PartnerRecognizes the hospital for conducting DNB/PG programmes for doctors in various oncology specializations.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Basavatarakam Indo American Cancer Hospital & Research Institute competitors and assessment

Company assessment

Broad incumbents

  • Max Institute of Cancer Care: Multi-specialty hospital group with dedicated cancer programs across North India offering radiation oncology, BMT, and surgical oncology — comparable in technology and academic depth but as part of a listed for-profit chain.
  • Apollo Cancer Centre (Apollo Hospitals): Large hospital chain with dedicated cancer centers across India including Hyderabad, offering surgical, medical, and radiation oncology with PET CT, LINACs, and BMT — comparable services but as part of a multi-specialty for-profit group with broader footprint.
  • Cancer Treatment Centers of America / City of Hope: US-based specialty oncology network (now part of City of Hope) offering integrated cancer care with strong translational research and academic programs — analogous in mission to integrate research, training, and multi-modality cancer treatment.
  • Medanta - The Medicity (Cancer Institute): Multi-specialty tertiary hospital in Gurugram/Delhi NCR with dedicated cancer care division including radiation, medical, and surgical oncology — comparable in equipment breadth (LINACs, PET CT, robotic surgery) but with broader non-oncology portfolio.

Others

  • Cancer Aid Society / Indian Cancer Society: Indian non-profit organizations focused on cancer awareness, screening camps, and patient support — adjacent peer reflecting the charitable cancer-care ecosystem that BIACH participates in for community outreach and underprivileged patient funding.

Direct peers

  • Tata Memorial Hospital: India's premier public specialty cancer hospital based in Mumbai, offering comprehensive surgical, medical, and radiation oncology with extensive research and DNB training programs — directly comparable in scope, mission, and academic depth to BIACH.
  • HCG (HealthCare Global Enterprises): India's largest cancer hospital chain with multiple centers including Hyderabad, specializing in medical, surgical, and radiation oncology with advanced LINAC fleets and BMT — closest pure-play oncology network peer in scale and tech stack.
  • Rajiv Gandhi Cancer Institute and Research Centre: Not-for-profit specialty cancer hospital in Delhi offering comprehensive oncology services, NABH accreditation, and academic programs — a close analogue in nonprofit trust structure and tertiary cancer care scope.
  • AIIMS (All India Institute of Medical Sciences) - Oncology Centre: Premier public academic medical institution with dedicated cancer treatment facilities (Dr. B.R.A. IRCH) in Delhi — comparable in academic mission, subsidized care, and tertiary oncology scope as a public-sector trust analogue.

Regional players

  • Basel Cancer Institute (University Hospital Basel): European specialty cancer center combining clinical care, research, and teaching — a useful cross-regional benchmark for academic comprehensive cancer center operations though it serves a different geography.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Basavatarakam Indo American Cancer Hospital & Research Institute social profiles

Digital presence

Basavatarakam Indo American Cancer Hospital & Research Institute compliance and trust

Trust signal

Compliance6 records

Basavatarakam Indo American Cancer Hospital & Research Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Basavatarakam Indo American Cancer Hospital & Research Institute leadership team

Management profile

Number of profiles

Basavatarakam Indo American Cancer Hospital & Research Institute subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Basavatarakam Indo American Cancer Hospital & Research Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Basavatarakam Indo American Cancer Hospital & Research Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Basavatarakam Indo American Cancer Hospital & Research Institute

What does Basavatarakam Indo American Cancer Hospital & Research Institute do?

Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital providing comprehensive cancer diagnosis, treatment, and research services including surgical oncology, medical oncology, and radiation oncology. The hospital operates advanced medical technology including PET CT with Cyclotron, Tomotherapy, robotic surgery systems, and six linear accelerators. It also runs a Bone Marrow Transplant unit, dedicated international patient coordination, DNB/PG medical training programs, and nursing and paramedical education, supported by scientific collaboration with Weill Cornell and Presbyterian Hospital, New York.

Is Basavatarakam Indo American Cancer Hospital & Research Institute a public or private company?

Basavatarakam Indo American Cancer Hospital & Research Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Basavatarakam Indo American Cancer Hospital & Research Institute founded?

Basavatarakam Indo American Cancer Hospital & Research Institute was founded in 2000. It employs 5,001 to 10,000 people.

Where is Basavatarakam Indo American Cancer Hospital & Research Institute based?

Basavatarakam Indo American Cancer Hospital & Research Institute is headquartered in Hyderabad, India, in the Asia region.

How does Basavatarakam Indo American Cancer Hospital & Research Institute make money?

Three revenue lines are on record. Patient Treatment Services are the primary driver. The others are government Healthcare Schemes and donations and Charitable Contributions.

Who are Basavatarakam Indo American Cancer Hospital & Research Institute's main competitors?

Broad incumbents on record are Max Institute of Cancer Care, Apollo Cancer Centre (Apollo Hospitals), Cancer Treatment Centers of America / City of Hope and Medanta - The Medicity (Cancer Institute). Cancer Aid Society / Indian Cancer Society is listed as an others. Direct peers are Tata Memorial Hospital, HCG (HealthCare Global Enterprises), Rajiv Gandhi Cancer Institute and Research Centre and AIIMS (All India Institute of Medical Sciences) - Oncology Centre. Basel Cancer Institute (University Hospital Basel) is listed as a regional player.

Does Basavatarakam Indo American Cancer Hospital & Research Institute have an API?

No public API is recorded for Basavatarakam Indo American Cancer Hospital & Research Institute.

What industry is Basavatarakam Indo American Cancer Hospital & Research Institute in?

Basavatarakam Indo American Cancer Hospital & Research Institute's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerTelangana HC rules hospitals on govt land bound to provide free care to poorThe Telangana High Court ruled that private hospitals allotted public land at concessional rates are legally obligated to provide free treatment to poor patients, directing Basavatarakam Indo-American Cancer Hospital and Research Institute to admit a breast cancer patient under its mandatory 25% free inpatient quota. The court cited government orders GOMs No. 434 and GOMs No. 80, which required the hospital to reserve 25% of inpatient beds and 40% of outpatient services for poor patients in exchange for the allotment of approximately 7.35 acres of government land in Banjara Hills. The matter has been posted for further hearing on July 23, with the District Medical and Health Officer directed to monitor compliance with these obligations.Deccan ChronicleAP Health Minister Assures Support to Young Cancer PatientAP Health Minister Y. Satya Kumar Yadav visited Basavatarakam Indo American Cancer Hospital & Research Institute in Hyderabad on Sunday to check on a six-year-old cancer patient named Sasani Chandrika, who has a cancerous tumour below her eye. Deputy Chief Minister K. Pawan Kalyan had directed the minister to approach hospital chairman Nandamuri Balakrishna seeking immediate help for the child, whose father has died leaving the family in severe financial distress.Medical BuyerIndia records 15 lakh new cancer cases every yearUnion Minister Anupriya Patel addressed the silver jubilee celebrations of Basavatarakam Indo American Cancer Hospital and Research Institute, highlighting that India records nearly 15 lakh new cancer cases every year. She outlined government cancer-control initiatives including expanded screening under the Ayushman Bharat programme for individuals above 30 and a free HPV vaccination programme for eligible adolescent girls to prevent cervical cancer. The minister praised the hospital's 25-year contribution, noting it has treated over 3.75 lakh patients and demonstrated quality cancer treatment at affordable costs.The HinduIndia reports 15 lakh new cancer cases annually, focus must be on prevention and early diagnosis, says Anupriya PatelUnion Minister of State for Health Anupriya Patel addressed the silver jubilee celebrations of the Basavatarakam Indo-American Cancer Hospital and Research Institute in Hyderabad, stating that with nearly 15 lakh new cancer cases reported annually in India, early detection and prevention must remain the country's primary focus. The hospital, which began with 100 beds 25 years ago, has expanded into a 650-bed facility with over 250 oncology specialists, supported by advanced radiation and bone marrow transplantation programmes. Telangana Health Minister also noted that the state has declared cancer a notifiable disease and established a cancer registry and dedicated reporting portal.The HinduEating smoked meat may cause esophageal cancer, say doctorsThe International Society for Diseases of the Esophagus (ISDE) hosted the ISDE India Edition 2026 conference in association with Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), marking the hospital's silver jubilee. The two-day event drew over 150 oncologists from Canada, Singapore, Japan, Australia, and the USA alongside Indian clinicians and researchers to share advancements in esophageal cancer research and clinical expertise. The conference highlighted India's growing role in the field of esophageal cancer diagnosis and treatment.